From:Compression Medical Distributors, inc.

The DermaFloat APL is an advanced alternating pressure Low Air Loss therapeutic mattress replacement system that provides pressure redistribution and a comfortable, safe healing environment for the treatment and prevention of pressure ulcers up to Stage IV. Alternating pressure therapy has been demonstrated to reduce the risk of pressure ulcers as well as being a valuable aid in the treatment of those identified as being at risk of developing pressure ulcers. Also, the use of the integrated CairRails mitigates risk and provides your patient with a safe, secure healing environment.

Mattress features:

• Twenty individual cells help evenly distribute resident’s weight and maximize pressure redistribution

• Low shear and low friction therapy pad is treated with an antibacterial and antifungal agent and is fluid proof and moisture vapor permeable

• CairRails risk management side air bolsters

• Lightweight mattress rolls up for portability and ease of storage

• Mattress stays inflated for up to 12 hours in the event of power failure or during resident transport

• Mattress size: 36" W x 80" L x 8" D

• Maximum weight capacity: 350 lbs.

 Control unit features:

• Three modes of operation: Autofirm, Therapy and Alternate

• Autofirm mode provides maximum air inflation designed to assist both resident and caregiver during transfer and treatment

• Three alternating cycle times: 5, 10 and 15 minutes

• Five comfort control settings maximize resident compliance

• Automatic panel lockout to avoid unwanted or unintended adjustments

• CPR quick deflation • UL/CUL Listed

Product Brochure

Product Manual